| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/24/2007 | US7247608 FGF homolog polypeptides |
| 07/24/2007 | US7247477 For use in tissue engineering, research, diagnostics |
| 07/24/2007 | US7247445 2-O sulfatase compositions and methods of hydrolyzing therewith |
| 07/24/2007 | CA2192480C Benzopyrans and their use as therapeutic agents |
| 07/19/2007 | WO2007081530A2 Endoluminal medical device for local delivery of cathepsin inhibitors |
| 07/19/2007 | WO2007081206A1 A method of treating an acute vascular disorder |
| 07/19/2007 | WO2007081031A1 Glycosyltransferase inhibitor |
| 07/19/2007 | WO2007081030A1 Pyrrolopyridazinone compound |
| 07/19/2007 | WO2007080787A1 Coenzyme q10-containing water-soluble compositions |
| 07/19/2007 | WO2007080515A1 Thrombosis preventing krill extract |
| 07/19/2007 | WO2007080325A1 Fgf-receptor agonist dimeric compounds |
| 07/19/2007 | WO2007080074A1 Solid pharmaceutical composition comprising irbesartan |
| 07/19/2007 | WO2007079862A1 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 07/19/2007 | WO2007079861A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 07/19/2007 | WO2006037623A3 New nuclear transcription factors regulators |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070167611 Peptides and Peptidomimetics with Structural Similarity to Human p53 that Activate p53 Function |
| 07/19/2007 | US20070167511 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder |
| 07/19/2007 | US20070167503 Substituted benzoxazoles as estrogenic agents |
| 07/19/2007 | US20070167501 Bicyclo derivative |
| 07/19/2007 | US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof |
| 07/19/2007 | US20070167483 Phenylalanine Enamide Derivatives |
| 07/19/2007 | US20070167461 USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a] PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS |
| 07/19/2007 | US20070167459 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 07/19/2007 | US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder |
| 07/19/2007 | US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES |
| 07/19/2007 | US20070167411 Compositions for treating angina |
| 07/19/2007 | US20070167406 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 07/19/2007 | US20070167386 Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same |
| 07/19/2007 | US20070167373 Combined use of a GLP-1 compound and a modulator of diabetic late complications |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070166376 Solid pharmaceutical preparation |
| 07/19/2007 | US20070166314 EpA2 monoclonal antibodies and methods of use thereof |
| 07/19/2007 | DE102006002164A1 Verfahren zur Unterdrückung endogener Oxidantien durch Stabilisierung mitochondrialer Membranen in der Behandlung aller Alterungsphänomene A method of suppressing endogenous oxidants by stabilization of mitochondrial membranes in the treatment of all aging phenomena |
| 07/19/2007 | DE102005055963A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 07/19/2007 | CA2637388A1 Pyrrolopyridazinone compound |
| 07/19/2007 | CA2636663A1 Solid pharmaceutical composition comprising irbesartan |
| 07/19/2007 | CA2636638A1 A method of treating an acute vascular disorder |
| 07/19/2007 | CA2633701A1 Novel, acyclically substitued furopyrimidine derivatives and use thereof |
| 07/19/2007 | CA2633698A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 07/18/2007 | EP1808484A1 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/18/2007 | EP1808176A2 5 alpha reduced glucocorticoid metabolites for the treatment of inflammation |
| 07/18/2007 | EP1808172A2 Botanical extract compositions and methods of use |
| 07/18/2007 | EP1807510A1 Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
| 07/18/2007 | EP1807505A1 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
| 07/18/2007 | EP1807429A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/18/2007 | EP1807407A1 Aromatic amides as inhibitors of c-fms kinase |
| 07/18/2007 | EP1807404A1 Novel use |
| 07/18/2007 | EP1807104A1 Botulinum toxin therapy of heart rhythm disorders |
| 07/18/2007 | EP1807099A2 Y2 selective receptor agonists for therapeutic interventions |
| 07/18/2007 | EP1807078A1 Diaminoalkane aspartic protease inhibitors |
| 07/18/2007 | EP1558598B1 Triazole compounds for the treatment of dysmenorrhoea |
| 07/18/2007 | EP1525204B1 Phenylalanine enamide derivatives |
| 07/18/2007 | EP1508566B1 (2s)-2-ethylphenylpropionic acid derivative |
| 07/18/2007 | EP1497436B1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 07/18/2007 | EP1458711B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 07/18/2007 | EP1403250B1 Bis(5-aryl-2-pyridyl) derivative |
| 07/18/2007 | EP1372702B1 Treatment of hypoxia/ischaemia related blood flow resistance using beta-interferon |
| 07/18/2007 | EP1285002B1 Regulating lipid levels via the zmax1 or hbm gene |
| 07/18/2007 | EP1180097B1 Mutual salt of amlodipine and atorvastatin |
| 07/18/2007 | EP1139753B1 Formulations for treating disease and methods of using same |
| 07/18/2007 | CN1326855C Ring fused pyrazole derivatives |
| 07/18/2007 | CN1326848C Aminopyrazole derivatives |
| 07/18/2007 | CN1326845C Process for preparing bis-phenyl fluorozine |
| 07/18/2007 | CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/18/2007 | CN1326839C 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use |
| 07/18/2007 | CN1326814C Process for preparing Erigeron breviscapus active component |
| 07/18/2007 | CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/18/2007 | CN1326562C Use of IL-18 inhibitors for treatment and/or prevention of heart disease |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN1326558C Chinese herbal medicine oral liquid for treating high blood pressure and its preparation method |
| 07/18/2007 | CN1326531C Health care tea for preventing cancer, lowering blood fat and lowering blood pressure |
| 07/18/2007 | CN1326530C Method for extracting spore oil from exosporium-broken spore of glossy ganoderma |
| 07/18/2007 | CN1326529C Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma |
| 07/18/2007 | CN1326527C Dispersible tablet of puerarin and its preparation process |
| 07/18/2007 | CN1326520C A pharmaceutical composition and application thereof in preparation of medicine for preventing or treating cerebrovascular and cardiovascular disease |
| 07/18/2007 | CN101001948A Procollagen IIA deficient mice |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN101001852A Pyrazole derivative |
| 07/18/2007 | CN101001836A Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/18/2007 | CN101001629A Medicinal composition |
| 07/18/2007 | CN101001624A Compositions comprising flavonoids and tocotrienols and methods thereof |
| 07/18/2007 | CN100999512A Isochromanone 4 derivate, its preparation process and therapeutic use |
| 07/18/2007 | CN100999470A Salvia minium phenolic acid A and process of preparing preparation and use |
| 07/18/2007 | CN100998870A Stable polymer micelle medicine carrging system |
| 07/18/2007 | CN100998869A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998861A Cerebroprotein hydrolysate sodium chloride injection |
| 07/18/2007 | CN100998859A Chinese medicine for treating obstruction of qi in the chest and its preparation method |
| 07/18/2007 | CN100998856A Oral Chinese medicine for treating abalienation type hypertension |
| 07/18/2007 | CN100998855A Oral Chinese medicine for treating severe headache type hypertension |
| 07/18/2007 | CN100998854A Oral Chinese medicine for treating chest tightness type hypertension |
| 07/18/2007 | CN100998847A Oral Chinese medicine for treating throat pain type virus myocarditis |
| 07/18/2007 | CN100998842A Chinese horbal medicinal pill for treating coronary heart disease |
| 07/18/2007 | CN100998835A Preparation for treating angiocardiopathy and its preparation method |
| 07/18/2007 | CN100998833A Oral Chinese medicine for treating brain arteriosclerosis due to hyperactivity of liver-yang |
| 07/18/2007 | CN100998832A Orally taken Chinese medicine for treating action disturbance brain arteriosclerosis |
| 07/18/2007 | CN100998831A Orally taken Chinese medicine for treating brain arteriosclerosis due to qi deficieney |
| 07/18/2007 | CN100998830A Orally taken Chinese medicine for treating phlegm turbitity type brain arteriosclerosis |
| 07/18/2007 | CN100998829A Oral administration Chinese medicine for treating brain arteriosclerosis |
| 07/18/2007 | CN100998828A Oral Chinese medicine for treating extremity numbness type brain arteriosclerosis |